From Karolinska Hospital, Stockholm, Sweden (M.R.); Ruprecht-Karls
University of Heidelberg, Heidelberg, Germany (T.B.); Westfälische
Wilhelms Universität, Münster, Germany (M.B.); Academic Hospital
Maastricht, the Netherlands (K.d.D.); and Bakken Research Center, Maastricht,
the Netherlands (J.M., F.L.).
Correspondence to Mårten Rosenqvist, MD, Department of Cardiology, Karolinska Hospital, 171.76 Stockholm, Sweden. E-mail mro{at}cardio.ks.se
Background—A newly developed
classification system relates adverse events to the surgical procedure
or the function of the implantable defibrillator.
Methods and Results—Adverse events were monitored during
prospective clinical evaluation of the Medtronic model 7219 Jewel ICD
and were classified according to the definitions of the ISO 14155
standard for device clinical trials into 3 groups: severe and mild
device-related and severe non–device-related adverse events. In
addition, events were related to the surgical procedure, treatment with
the device, or cardiac function. Seven hundred seventy-eight patients
were followed up for an average of 4.0 months after ICD implantation.
In total, 356 adverse events were observed in 259 patients. At 1, 3,
and 12 months after ICD implantation, 99%, 98%, and 97% of the
patients, respectively, survived; 95%, 93%, and 92%, respectively,
were free of surgical reintervention; and 79%, 68%, and 51%,
respectively, were free of any adverse event. Twenty patients died: 6
deaths were related to the surgical procedure, 12 deaths were
considered unrelated to ICD treatment, and 2 patients died of an
unknown cause. Of 111 nonlethal severe adverse device effects, 47
required surgical intervention, 19 times for correction of a dislodged
lead. Inappropriate delivery of therapy was observed 128 times in 111
patients, and the events were typically resolved by reprogramming or
drug adjustment. Nine of these required rehospitalization.
Conclusions—Approximately 50% of patients experience an adverse
event within the first year after ICD implantation. The observed
adverse event rate depends on the definitions and the prospective
monitoring. The incidence of inappropriate therapy emphasizes the need
for improved detection algorithms and for quality-of-life evaluations,
especially when considering ICD treatment in high-risk but
arrhythmia-free patients.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators
A Prospective Multicenter Study
Key Words: events, adverse • tachyarrhythmias • defibrillation • implantable cardioverter defibrillator (ICD)
This article has been cited by other articles:
 |
|
 |
|
  A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Daubert, W. Zareba, D. S. Cannom, S. McNitt, S. Z. Rosero, P. Wang, C. Schuger, J. S. Steinberg, S. L. Higgins, D. J. Wilber, et al. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II: Frequency, Mechanisms, Predictors, and Survival Impact J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1357 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Salerno-Uriarte, G. M. De Ferrari, C. Klersy, R. F.E. Pedretti, M. Tritto, L. Sallusti, L. Libero, G. Pettinati, G. Molon, A. Curnis, et al. Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy: Results of the ALPHA Study J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1896 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Almendral and M. E. Josephson All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator Circulation, September 4, 2007; 116(10): 1204 - 1212. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singh and M. M. Murawski Implantable Cardioverter Defibrillator Therapy and the Need for Concomitant Antiarrhythmic Drugs Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 175 - 180. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Agard, R. Lofmark, N. Edvardsson, and I. Ekman Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation J. Med. Ethics, September 1, 2007; 33(9): 514 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction Ann Intern Med, August 21, 2007; 147(4): 251 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vollmann, L. Luthje, and M. Zabel Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy Europace, May 1, 2007; 9(5): 275 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Gehi, D. Mehta, and J. A. Gomes Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock JAMA, December 20, 2006; 296(23): 2839 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Chan, K. Stein, T. Chow, M. Fendrick, J. T. Bigger, and S. Vijan Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II-Eligible Population J. Am. Coll. Cardiol., July 4, 2006; 48(1): 112 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Reynolds, D. J. Cohen, A. D. Kugelmass, P. P. Brown, E. R. Becker, S. D. Culler, and A. W. Simon The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2493 - 2497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Bloomfield, J. T. Bigger, R. C. Steinman, P. B. Namerow, M. K. Parides, A. B. Curtis, E. S. Kaufman, J. M. Davidenko, T. S. Shinn, and J. M. Fontaine Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction J. Am. Coll. Cardiol., January 17, 2006; 47(2): 456 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, D. C. Kambouraki, D. A. Arfanakis, and P. E. Vardas Amino-Terminal Pro-Brain Natriuretic Peptide Predicts Ventricular Arrhythmogenesis in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillators Chest, October 1, 2005; 128(4): 2604 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.J. Jordaens and J.M. Mekel Electrical storm in the ICD era Europace, January 1, 2005; 7(2): 181 - 183. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Senges-Becker, M. Klostermann, R. Becker, A. Bauer, K. E. Siegler, H. A. Katus, and W. Schoels What is the "Optimal" follow-up schedule for ICD patients? Europace, January 1, 2005; 7(4): 319 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A.M.J. Theuns, A. P. J. Klootwijk, D. M. Goedhart, and L. J.L.M. Jordaens Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2362 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Bloomfield, R. C. Steinman, P. B. Namerow, M. Parides, J. Davidenko, E. S. Kaufman, T. Shinn, A. Curtis, J. Fontaine, D. Holmes, et al. Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum Circulation, October 5, 2004; 110(14): 1885 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Becker, J. Ruf-Richter, J. C. Senges-Becker, A. Bauer, S. Weretka, F. Voss, H. A. Katus, and W. Schoels Patient alert in implantable cardioverter defibrillators: toy or tool? J. Am. Coll. Cardiol., July 7, 2004; 44(1): 95 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wichter, M. Paul, C. Wollmann, T. Acil, P. Gerdes, O. Ashraf, T. D.T. Tjan, R. Soeparwata, M. Block, M. Borggrefe, et al. Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients Circulation, March 30, 2004; 109(12): 1503 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Samore, R. S. Evans, A. Lassen, P. Gould, J. Lloyd, R. M. Gardner, R. Abouzelof, C. Taylor, D. A. Woodbury, M. Willy, et al. Surveillance of Medical Device-Related Hazards and Adverse Events in Hospitalized Patients JAMA, January 21, 2004; 291(3): 325 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kostopoulou, E. Sbarouni, E. G. Livanis, G. N. Theodorakis, and D. Kremastinos Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient Europace, January 1, 2004; 6(3): 205 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Przybylski, R. Baranowski, J. J. Zebrowski, and H. Szwed Verification of implantable cardioverter defibrillator (ICD) interventions by nonlinear analysis of heart rate variability - preliminary results Europace, January 1, 2004; 6(6): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Stevenson and L. M. Epstein Predicting Sudden Death Risk for Heart Failure Patients in the Implantable Cardioverter-Defibrillator Age Circulation, February 4, 2003; 107(4): 514 - 516. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Rojo-Alvarez, A. Arenal, A. Garcia-Alberola, M. Ortiz, M. Valdes, and A. Artes-Rodriguez A new algorithm for rhythm discrimination in cardioverter defibrillators based on the initial voltage changes of the ventricular electrogram Europace, January 1, 2003; 5(1): 77 - 82. [Abstract] [PDF]
|
|
|
|
|
|
G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction Ann Intern Med, November 20, 2001; 135(10): 870 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.N.W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P.E. Vardas Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology Eur. Heart J., July 1, 2001; 22(13): 1074 - 1081. [PDF]
|
|
|
|
|
|
M. H. Gollob and J. J. Seger Current Status of the Implantable Cardioverter-Defibrillator Chest, April 1, 2001; 119(4): 1210 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P. E. Vardas Indications for implantable cardioverter defibrillator (ICD) therapy: Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology Europace, January 1, 2001; 3(3): 169 - 176. [PDF]
|
|
|
|
 |
|
 K. Glatter and L. B. Liem Implantable Cardioverter Defibrillator: Current Progress and Management Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2000; 4(3): 162 - 179. [Abstract] [PDF]
|
|
|
|
|
|
T. Korte, W. Jung, G. Ostermann, C. Wolpert, S. Spehl, B. Esmailzadeh, and B. Luderitz Hospital readmission after transvenous cardioverter/defibrillator implantation. A single centre study Eur. Heart J., July 2, 2000; 21(14): 1186 - 1191. [Abstract] [PDF]
|
|
|
|
|
|
A. Englund, S. Behrens, K. Wegscheider, E. Rowland, and for the European 7219 Jewel Investigators Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1560 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Podrid Redefining the Role of Antiarrhythmic Drugs N. Engl. J. Med., June 17, 1999; 340(24): 1910 - 1912. [Full Text]
|
|